Lincoln Pharmaceuticals Limited

BSE:531633 Stock Report

Market Cap: ₹16.1b

Lincoln Pharmaceuticals Management

Management criteria checks 3/4

Lincoln Pharmaceuticals' CEO is Mahendrabhai Patel, appointed in Jun 2018, has a tenure of 6.58 years. total yearly compensation is ₹4.93M, comprised of 99.4% salary and 0.6% bonuses, including company stock and options. directly owns 6.52% of the company’s shares, worth ₹1.05B. The average tenure of the management team and the board of directors is 6.2 years and 10.2 years respectively.

Key information

Mahendrabhai Patel

Chief executive officer

₹4.9m

Total compensation

CEO salary percentage99.4%
CEO tenure6.6yrs
CEO ownership6.5%
Management average tenure6.2yrs
Board average tenure10.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Mahendrabhai Patel's remuneration changed compared to Lincoln Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹966m

Jun 30 2024n/an/a

₹980m

Mar 31 2024₹5m₹5m

₹933m

Dec 31 2023n/an/a

₹873m

Sep 30 2023n/an/a

₹808m

Jun 30 2023n/an/a

₹769m

Mar 31 2023₹3m₹3m

₹729m

Dec 31 2022n/an/a

₹714m

Sep 30 2022n/an/a

₹674m

Jun 30 2022n/an/a

₹667m

Mar 31 2022₹3m₹3m

₹694m

Dec 31 2021n/an/a

₹709m

Sep 30 2021n/an/a

₹668m

Jun 30 2021n/an/a

₹647m

Mar 31 2021₹3m₹3m

₹623m

Dec 31 2020n/an/a

₹586m

Sep 30 2020n/an/a

₹560m

Jun 30 2020n/an/a

₹540m

Mar 31 2020₹2m₹2m

₹514m

Dec 31 2019n/an/a

₹510m

Sep 30 2019n/an/a

₹492m

Jun 30 2019n/an/a

₹453m

Mar 31 2019₹2m₹2m

₹487m

Dec 31 2018n/an/a

₹470m

Sep 30 2018n/an/a

₹495m

Jun 30 2018n/an/a

₹458m

Mar 31 2018₹2m₹2m

₹346m

Compensation vs Market: Mahendrabhai's total compensation ($USD57.26K) is below average for companies of similar size in the Indian market ($USD181.71K).

Compensation vs Earnings: Mahendrabhai's compensation has increased by more than 20% in the past year.

CEO

Mahendrabhai Patel (70 yo)

6.6yrs

Tenure

₹4,925,000

Compensation

Mr. Mahendrabhai Gulabdas Patel, B.A, LLB serves as Managing Director of Lincoln Pharmaceuticals Ltd since June 08, 2018. Mr. Patel has varied experience of chemicals, steel, finance etc. Mr. Patel handles...

Leadership Team

NamePositionTenureCompensationOwnership
Mahendrabhai Patel
MD & Whole Time Director6.6yrs₹4.93m6.52%
₹ 1.1b
Darshit Shah
Chief Financial Officer5.8yrs₹1.32mno data
Trusha Shah
Company Secretary & Compliance Officer2.2yrs₹589.00kno data
Ashish Patel
Whole Time Directorno data₹6.64m11.63%
₹ 1.9b
Hashmukhbhai Patel
Whole Time Director30yrs₹3.81m1.87%
₹ 301.0m
Munjal Patel
Whole Time Directorno data₹6.65m13.37%
₹ 2.2b
Sanjay Bhatt
Senior Manager of Operationno datano datano data
Laxmikant Harsola
Vice President of Technicalno datano datano data
Sanjiv Patel
Senior Manager of Planning & Administrationno datano datano data
Amit Dwivedi
Group Marketing Managerno datano datano data
Anil Verma
Sales and Distributor Headno datano datano data
Sachin Kapoor
Head of H R Dno datano datano data

6.2yrs

Average Tenure

45.5yo

Average Age

Experienced Management: 531633's management team is seasoned and experienced (6.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mahendrabhai Patel
MD & Whole Time Director30yrs₹4.93m6.52%
₹ 1.1b
Ashish Patel
Whole Time Director10.2yrs₹6.64m11.63%
₹ 1.9b
Hashmukhbhai Patel
Whole Time Director30yrs₹3.81m1.87%
₹ 301.0m
Munjal Patel
Whole Time Director10.2yrs₹6.65m13.37%
₹ 2.2b
Rajnikant Patel
Non-Executive Director30yrsno data3.78%
₹ 609.8m
Kishorbhai Shah
Non-Executive Chairman29.4yrsno data2.39%
₹ 385.5m
Saurin Jagdish Parikh
Independent Non-Executive Director6.8yrsno datano data
Nareshkumar Suthar
Independent Directorless than a yearno datano data
Seema Mehta
Woman Independent Directorless than a yearno datano data

10.2yrs

Average Tenure

64yo

Average Age

Experienced Board: 531633's board of directors are seasoned and experienced ( 10.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 13:28
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lincoln Pharmaceuticals Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research